Zimmer Biomet Raises €500M & $500M in New Secured Bonds—Key Details RevealedZimmer Biomet launches €500 M Euro notes & $500 M U.S. notes – secured debt, 2033/2036 maturities, SEC‑approved, boosting capital for future R&D.ZIMMER BIOMET HOLDINGS INC Health Care Health Care Equipment & Services AI generated Dr. Sarah Winters 15/11/2026, 17:17 3 minutes to read
Atlas Antibodies Names Morten Henneveld as Interim CEO to Drive GrowthAtlas Antibodies appoints experienced interim CEO Morten Henneveld to drive growth in rare‑disease and oncology antibody programs, ensuring continuity and investor confidence.ZIMMER BIOMET HOLDINGS INC Health Care Health Care Equipment & Services AI generated Dr. Sarah Winters 04/11/2026, 02:32 2 minutes to read